TREATMENT OF PYOINFLAMMATORY COMPLICATIONS WITH INDIVIDUALLY SELECTED OZONE DOSE IN PATIENTS WITH DIABETES

Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/14291

Full metadata record

DC Field	Value	Language
dc.contributor.author	Karatieieva, S.
dc.contributor.author	Makarova, O.
dc.contributor.author	Yurkiv, O.
dc.contributor.author	Semenenko, S.
dc.contributor.author	Berezova, M.S.	en
dc.date.accessioned	2018-10-01T09:59:48Z
dc.date.available	2018-10-01T09:59:48Z
dc.date.issued	2018
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/14291
dc.description.abstract	The severity of purulent-inflammatory process in patients with diabetes mellitus is determined by lymphocytotoxic test. The test shows that application of intravenous ozone therapy with individually selected ozone dose significantly decreases the spread of necrotic suppurative focus already on the third day of treatment. Granulation tissue and marginal epithelization in the wound develops on the 6-8th day of hospitalization; normalization of glycemic levels shorten of the period of the hospital stay up to 3-5 days, compared to the control group.	ru_RU
dc.language.iso	en_US	ru_RU
dc.publisher	GEORGIAN MEDICAL NEWS No 2 (275) 2018	ru_RU
dc.subject	pyoinflammatory complications	ru_RU
dc.subject	diabetes mellitus	ru_RU
dc.subject	ozonotherapy	ru_RU
dc.title	TREATMENT OF PYOINFLAMMATORY COMPLICATIONS WITH INDIVIDUALLY SELECTED OZONE DOSE IN PATIENTS WITH DIABETES	ru_RU
dc.type	Article	ru_RU
Appears in Collections:	Статті. Кафедра догляду за хворими та вищої медсестринської освіти

Files in This Item:

File	Description	Size	Format
91-94-11-14.pdf		383.64 kB	Adobe PDF	View/Open

DSpace JSPUI